Study Of Adults And Adolescents With Vasomotor Rhinitis
NCT ID: NCT00117325
Last Updated: 2018-03-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
352 participants
INTERVENTIONAL
2005-07-11
2006-02-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis
NCT00118703
Perennial Allergic Rhinitis Study In Pediatric Subjects
NCT00108914
Study In Adults And Adolescents With Seasonal Allergic Rhinitis.
NCT00225823
Seasonal Allergic Rhinitis In Pediatric Subjects
NCT00107757
A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).
NCT00103454
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GW685698X
GW685698X
GW685698X
Aqueous Nasal Spray 100mcg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GW685698X
Aqueous Nasal Spray 100mcg
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of VMR.
* Literate in English or native language.
Exclusion Criteria
* Use corticosteroids or other allergy medications during the study.
* Used tobacco products within the past year.
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GlaxoSmithKline
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
GSK Clinical Trials
Role: STUDY_DIRECTOR
GlaxoSmithKline
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GSK Investigational Site
Beverly Hills, California, United States
GSK Investigational Site
Huntington Beach, California, United States
GSK Investigational Site
Mission Viejo, California, United States
GSK Investigational Site
San Diego, California, United States
GSK Investigational Site
San Diego, California, United States
GSK Investigational Site
Santa Barbara, California, United States
GSK Investigational Site
Colorado Springs, Colorado, United States
GSK Investigational Site
Englewood, Colorado, United States
GSK Investigational Site
Fort Collins, Colorado, United States
GSK Investigational Site
Woodstock, Georgia, United States
GSK Investigational Site
Chicago, Illinois, United States
GSK Investigational Site
Evansville, Indiana, United States
GSK Investigational Site
Louisville, Kentucky, United States
GSK Investigational Site
Covington, Louisiana, United States
GSK Investigational Site
Shreveport, Louisiana, United States
GSK Investigational Site
Bangor, Maine, United States
GSK Investigational Site
Baltimore, Maryland, United States
GSK Investigational Site
Rockville, Maryland, United States
GSK Investigational Site
Novi, Michigan, United States
GSK Investigational Site
Ypsilanti, Michigan, United States
GSK Investigational Site
Minneapolis, Minnesota, United States
GSK Investigational Site
Mount Laurel, New Jersey, United States
GSK Investigational Site
Liverpool, New York, United States
GSK Investigational Site
Rochester, New York, United States
GSK Investigational Site
Canton, Ohio, United States
GSK Investigational Site
Cincinnati, Ohio, United States
GSK Investigational Site
North Olmsted, Ohio, United States
GSK Investigational Site
Lake Oswego, Oregon, United States
GSK Investigational Site
Portland, Oregon, United States
GSK Investigational Site
Easton, Pennsylvania, United States
GSK Investigational Site
Palmyra, Pennsylvania, United States
GSK Investigational Site
Pittsburgh, Pennsylvania, United States
GSK Investigational Site
Upland, Pennsylvania, United States
GSK Investigational Site
Charleston, South Carolina, United States
GSK Investigational Site
Orangeburg, South Carolina, United States
GSK Investigational Site
Germantown, Tennessee, United States
GSK Investigational Site
Knoxville, Tennessee, United States
GSK Investigational Site
Salt Lake City, Utah, United States
GSK Investigational Site
Kelowna, British Columbia, Canada
GSK Investigational Site
Hamilton, Ontario, Canada
GSK Investigational Site
Québec, , Canada
GSK Investigational Site
Litoměřice, , Czechia
GSK Investigational Site
Olomouc, , Czechia
GSK Investigational Site
Tábor, , Czechia
GSK Investigational Site
Kassel, Hesse, Germany
GSK Investigational Site
Hanover, Lower Saxony, Germany
GSK Investigational Site
Schwerin, Mecklenburg-Vorpommern, Germany
GSK Investigational Site
Geesthacht, Schleswig-Holstein, Germany
GSK Investigational Site
Hamburg, , Germany
GSK Investigational Site
Larvik, , Norway
GSK Investigational Site
Nesttun, , Norway
GSK Investigational Site
Bucharest, , Romania
GSK Investigational Site
Deva, , Romania
Countries
Review the countries where the study has at least one active or historical site.
Study Documents
Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.
Document Type: Clinical Study Report
For additional information about this study please refer to the GSK Clinical Study Register
View DocumentDocument Type: Statistical Analysis Plan
For additional information about this study please refer to the GSK Clinical Study Register
View DocumentDocument Type: Dataset Specification
For additional information about this study please refer to the GSK Clinical Study Register
View DocumentDocument Type: Study Protocol
For additional information about this study please refer to the GSK Clinical Study Register
View DocumentDocument Type: Individual Participant Data Set
For additional information about this study please refer to the GSK Clinical Study Register
View DocumentDocument Type: Informed Consent Form
For additional information about this study please refer to the GSK Clinical Study Register
View DocumentDocument Type: Annotated Case Report Form
For additional information about this study please refer to the GSK Clinical Study Register
View DocumentRelated Links
Access external resources that provide additional context or updates about the study.
Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FFR30006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.